Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5478217 | 0.83 | EPHX1 (0.31) | EPHX1 | |
| SCHEMBL7347382 | 0.78 | EPHX1 (0.40) | EPHX1 | |
| SCHEMBL1164584 | 0.77 | CPT2 (0.38) | ALDH1A1CYP2C19PIK3CD | |
| SCHEMBL17008763 | 0.77 | CPT2 (0.38) | ALDH1A1CYP2C19PIK3CD | |
| SCHEMBL19331402 | 0.77 | CPT2 (0.38) | ALDH1A1CYP2C19PIK3CD | |
| SCHEMBL28608502 | 0.73 | — | — | |
| SCHEMBL1647709 | 0.72 | ALOX15 (0.31) | — | |
| SCHEMBL1241898 | 0.72 | ALOX15 (0.31) | — | |
| SCHEMBL277089 | 0.70 | CA1 (0.32) | PIK3CD | |
| SCHEMBL158887 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104039767-A | N- (pyridin-4-yl) amides and N- (pyrimidin-4-yl) amides and their pharmaceutical and cosmetic use | GALDERMA RES & DEV | 2014-09-10 | — | — | CN | claimed |
| EP-2654665-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA Pharma Gesellschaft für die Entwicklung und Vermarktung pharmazeutischer Produkte mbH (DE) | 2013-10-30 | — | — | EP | disclosed |
| WO-2012083906-A2 | METHOD FOR DEVELOPING A LIQUID COMPOSITION TO BE APPLIED TO THE SKIN AS A FOAM AND A COMPOSITION THAT CAN BE APPLIED TOPICALLY | MIKA PHARMA GESELLSCHAFT FÜR DIE ENTWICKLUNG UND VERMARKTUNG PHARMAZEUTISCHER PRODUKTE MBH (DE) | 2012-06-28 | — | — | WO | disclosed |